![Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community - ScienceDirect Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1665268119315595-gr1.jpg)
Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community - ScienceDirect
![Hepatocellular Carcinoma Imaging: Practice Essentials, Computed Tomography, Magnetic Resonance Imaging Hepatocellular Carcinoma Imaging: Practice Essentials, Computed Tomography, Magnetic Resonance Imaging](https://img.medscapestatic.com/pi/meds/ckb/86/17786tn.jpg)
Hepatocellular Carcinoma Imaging: Practice Essentials, Computed Tomography, Magnetic Resonance Imaging
![Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial - Annals of Oncology Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5bf0a71c-d630-4537-8efc-1e6a240875e5/gr1.jpg)
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial - Annals of Oncology
![Dermatologic Manifestations of Paraneoplastic Syndromes: Overview, Papulosquamous Disorders, Erythematous Lesions Dermatologic Manifestations of Paraneoplastic Syndromes: Overview, Papulosquamous Disorders, Erythematous Lesions](https://img.medscapestatic.com/pi/meds/ckb/00/6300tn.jpg)
Dermatologic Manifestations of Paraneoplastic Syndromes: Overview, Papulosquamous Disorders, Erythematous Lesions
![Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community | Annals of Hepatology Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community | Annals of Hepatology](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1665268119315595:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNeKOJqKH5+Za6P+RA5Vq9Dl1ls4wzUJsngboLvP5XMyp/YCv02Cmk4dyrIa6hQX0w4WTyIq16GTdoJadWQWXtE0ZNnIpXDQm3p6xsgixpqIpnht1hrU9h+5yCQXYiFXXplVxp9A7o/pY7TX8NGMcBDxR0ETuAuRG8mMHkaqzWncvi1LS8agBSxjWdh2MchxmnXZJRQ1MBkwo3gl0ETEEpKNK7qiWWvTPKt4lSCs5wbEAE4TujpeRR0aPuSWl5hyq6w=)
Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community | Annals of Hepatology
![Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial - Annals of Oncology Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0ea35c39-93fc-4e70-981e-701523259c75/gr3.jpg)
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial - Annals of Oncology
![Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial - Annals of Oncology Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/44d86ae9-6855-42c8-b94f-dc6a92ff0e62/gr2.jpg)